Browse Human Gene Sets

Gene set name:

 
  (Enter full or partial name)

By first letter:

 

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

By collection:

[about the MSigDB Human collections]

  • H (hallmark gene sets, 50 gene sets)
  • C1 (positional gene sets, 302 gene sets)
  • C2 (curated gene sets, 7837 gene sets)
    • CGP (chemical and genetic pertubations, 3560 gene sets)
    • CP (canonical pathways, 4277 gene sets)
  • C3 (regulatory gene sets, 3712 gene sets)
    • MIR (microRNA targets, 2598 gene sets)
    • TFT (all transcription factor targets, 1114 gene sets)
      • TFT:GTRD (GTRD transcription factor targets, 504 gene sets)
      • TFT:TFT_LEGACY (legacy transcription factor targets, 610 gene sets)
  • C4 (computational gene sets, 1006 gene sets)
    • 3CA (Curated Cancer Cell Atlas gene sets, 148 gene sets)
    • CGN (cancer gene neighborhoods, 427 gene sets)
    • CM (cancer modules, 431 gene sets)
  • C5 (ontology gene sets, 15849 gene sets)
    • GO (Gene Ontology, 9917 gene sets)
      • GO:BP (GO biological process, 6905 gene sets)
      • GO:CC (GO cellular component, 1094 gene sets)
      • GO:MF (GO molecular function, 1918 gene sets)
    • HPO (Human Phenotype Ontology, 5932 gene sets)
  • C6 (oncogenic gene sets, 189 gene sets)
  • C7 (immunologic gene sets, 5219 gene sets)
    • IMMUNESIGDB (ImmuneSigDB gene sets, 4872 gene sets)
    • VAX (vaccine response gene sets, 347 gene sets)
  • C8 (cell type signature gene sets, 866 gene sets)
  • C9 (computational perturbation signature gene sets, 62 gene sets)

Gene sets starting with V

Click on a gene set name to view its gene set page.

VALK_AML_CLUSTER_1
VALK_AML_CLUSTER_10
VALK_AML_CLUSTER_11
VALK_AML_CLUSTER_12
VALK_AML_CLUSTER_13
VALK_AML_CLUSTER_15
VALK_AML_CLUSTER_16
VALK_AML_CLUSTER_2
VALK_AML_CLUSTER_3
VALK_AML_CLUSTER_4
VALK_AML_CLUSTER_5
VALK_AML_CLUSTER_6
VALK_AML_CLUSTER_7
VALK_AML_CLUSTER_8
VALK_AML_CLUSTER_9
VALK_AML_WITH_11Q23_REARRANGED
VALK_AML_WITH_CEBPA
VALK_AML_WITH_EVI1
VALK_AML_WITH_FLT3_ITD
VALK_AML_WITH_T_8_21_TRANSLOCATION
VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP
VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_DN
VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP
VANASSE_BCL2_TARGETS_DN
VANASSE_BCL2_TARGETS_UP
VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN
VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP
VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP
VANDESLUIS_NORMAL_EMBRYOS_DN
VANDESLUIS_NORMAL_EMBRYOS_UP
VANGURP_PANCREATIC_ALPHA_CELL
VANGURP_PANCREATIC_BETA_CELL
VANGURP_PANCREATIC_DELTA_CELL
VANGURP_PANCREATIC_GAMMA_CELL
VANHARANTA_UTERINE_FIBROID_DN
VANHARANTA_UTERINE_FIBROID_UP
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP
VANLOO_SP3_TARGETS_DN
VANLOO_SP3_TARGETS_UP
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS
VANTVEER_BREAST_CANCER_BRCA1_DN
VANTVEER_BREAST_CANCER_BRCA1_UP
VANTVEER_BREAST_CANCER_ESR1_DN
VANTVEER_BREAST_CANCER_ESR1_UP
VANTVEER_BREAST_CANCER_METASTASIS_DN
VANTVEER_BREAST_CANCER_METASTASIS_UP
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS
VARELA_ZMPSTE24_TARGETS_DN
VARELA_ZMPSTE24_TARGETS_UP
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
VDR_Q3
VDR_Q6
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
VECCHI_GASTRIC_CANCER_EARLY_DN
VECCHI_GASTRIC_CANCER_EARLY_UP
VEGF_A_UP.V1_DN
VEGF_A_UP.V1_UP
VERHAAK_AML_WITH_NPM1_MUTATED_DN
VERHAAK_AML_WITH_NPM1_MUTATED_UP
VERHAAK_GLIOBLASTOMA_CLASSICAL
VERHAAK_GLIOBLASTOMA_MESENCHYMAL
VERHAAK_GLIOBLASTOMA_NEURAL
VERHAAK_GLIOBLASTOMA_PRONEURAL
VERNELL_RETINOBLASTOMA_PATHWAY_DN
VERNELL_RETINOBLASTOMA_PATHWAY_UP
VERNOCHET_ADIPOGENESIS
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1
VERRECCHIA_RESPONSE_TO_TGFB1_C1
VERRECCHIA_RESPONSE_TO_TGFB1_C2
VERRECCHIA_RESPONSE_TO_TGFB1_C3
VERRECCHIA_RESPONSE_TO_TGFB1_C4
VERRECCHIA_RESPONSE_TO_TGFB1_C5
VERRECCHIA_RESPONSE_TO_TGFB1_C6
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN
VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
VICENT_METASTASIS_UP
VIETOR_IFRD1_TARGETS
VILIMAS_NOTCH1_TARGETS_DN
VILIMAS_NOTCH1_TARGETS_UP
VILLANUEVA_LIVER_CANCER_KRT19_DN
VILLANUEVA_LIVER_CANCER_KRT19_UP
VISALA_AGING_LYMPHOCYTE_DN
VISALA_AGING_LYMPHOCYTE_UP
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP
VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP
VRTN_TARGET_GENES